A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants With Obesity or Overweight
Eli Lilly and Company
1,481 participants
Nov 17, 2023
INTERVENTIONAL
Conditions
Summary
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Administered SC. ISA specific interventions will be listed in the ISA.
Administered SC. ISA specific interventions will be listed in the ISA.
Administered SC. ISA specific interventions will be listed in the ISA.
Administered orally. ISA specific interventions will be listed in the ISA.
Administered SC. ISA specific interventions will be listed in the ISA.
Administered SC. ISA specific interventions will be listed in the ISA.
Administered orally. ISA specific interventions will be listed in the ISA.
Locations(54)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06143956